Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trial

Author(s):
Keystone, E.C.; Combe, B.; Smolen, J.; Strand, V.; Goel, N.; Vollenhoven, R. van; Mease, P.; Landewe, R.; Fleischmann, R.; Luijtens, K.; Heijde, D. van der
Published
2012
Publication type
Article / Letter to editor
certolizumab pegolrheumatoid arthritisefficacyRAPID 1ACR
Date issued
2012-09-30
Language
English
Is part of
Rheumatology (2012), Vol. 51, no. 9, p. 1628-1638
hdl
1887/118449
doi
10.1093/rheumatology/kes082